在主要是成年精神病医院住院患者中,甲基酸利用率的跨国差异
Bernd Hinney1, Simon Jost1, Sermin Toto2
1Molecular Psychiatry Lab, Faculty of Science and Medicine, University of Freiburg, Villars-sur-Glâne, Switzerland.
概括
成年精神病医院住院患者使用甲基酸盐 (MPH) 很少见,并因国家而异. 许多接受MPH治疗的患者没有确诊的ADHD诊断,这凸显了进一步研究的必要性.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床心理学 临床心理学
背景情况:
- 甲基 (MPH) 是一种中枢神经系统的兴奋剂.
- 它主要用于治疗注意力缺陷/多动障碍 (ADHD).
- 了解其在成人精神病医院住院患者中的使用模式至关重要.
研究的目的:
- 调查MPH利用的跨国差异.
- 分析德国,奥地利和瑞士成年精神病医院住院患者的MPH处方模式.
- 为了确定患者的特征和MPH用户的共同处方药物.
主要方法:
- 对AMSP药监计划 (2007-2017) 数据的回顾分析.
- 包括来自德国,奥地利和瑞士精神病医院的数据.
- 分析了102,740名住院患者,重点是接受MPH的560人.
主要成果:
- 在住院患者中,MPH的使用率为0.55%;在瑞士 (2%) 和德国/奥地利 (0.3%) 的使用率最高.
- 大多数接受MPH治疗的患者 (48.7%) 缺乏正式的ADHD诊断.
- 通常治疗的并发症包括抑郁症,神经质,人格和与物质有关的障碍.
结论:
- 成年MPH在住院精神病治疗中的使用很少,并且在国际上有相当大的差异.
- 没有ADHD诊断的高比例的患者表明非标签使用或诊断模两可.
- 需要在常规精神病学实践中对MPH指示,临床决策和治疗结果进行进一步的研究.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
630
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
630
Attention-Deficit/Hyperactivity Disorder
736
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
736
Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239


